Cercar
01/11/2022
Pharyngocutaneous fistula in irradiated patients: systematic review and our experience
Casasayas, M, Sansa, A, Garcia-Lorenzo, J, Venegas, MD, Quer, M, Leon, X. Pharyngocutaneous fistula in irradiated patients: systematic review and our experience. JOURNAL OF LARYNGOLOGY AND OTOLOGY. 2022; 136(11)DOI:10.1017/S0022215121004370. PMID:35791885. IF:1.700(Q3/7D).
01/11/2022
Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma
Bague, S, Leon, X, Terra, X, Lejeune, M, Camacho, M, Aviles-Jurado, FX. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2022; 44(11)DOI:10.1002/hed.27161. PMID:36207788. IF:2.900(Q1/2D).
01/09/2022
Usefulness of endonasal flaps and grafts in skull base surgery. Consensus document
Moreno-Luna R., Mariño Sánchez F., Kaen A., Gras Cabrerizo J.R., Mata Castro N., González García J., Villacampa Aubá J.M., Cárdenas Ruiz-Valdepeñas E., Monjas Cánovas I., del Cuvillo Bernal A., García Piñero A., Maza Solano J.M., Fernández de Liesa R., Sánchez-Gómez S., Alobid I.. Usefulness of endonasal flaps and grafts in skull base surgery. Consensus document. Acta Otorrinolaringologica Espanola. 2022; 73(5)DOI:10.1016/j.otorri.2021.02.005. PMID:34330369. IF:(Q/D).
01/08/2022
Concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
Mena, M, Wang, X, Tous, S, Quiros, B, Clavero, O, Alejo, M, Morey, F, Taberna, M, Vintro, XL, Rubio, BL, Alos, L, Mehanna, H, Quint, W, Pawlita, M, Tommasino, M, Pavon, MA, Munoz, N, De Sanjose, S, Bosch, FX, Alemany, L. Concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study. Cancers. 2022; 14(15)DOI:10.3390/cancers14153787. PMID:35954451. IF:5.200(Q2/3D).
01/06/2022
The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours
Lopez, F, Shah, JP, Beitler, JJ, Snyderman, CH, Lund, V, Piazza, C, Makitie, AA, Guntinas-Lichius, O, Rodrigo, JP, Kowalski, LP, Quer, M, Shaha, A, Homma, A, Sanabria, A, Ferrarotto, R, Lee, AWM, Lee, VHF, Rinaldo, A, Ferlito, A. The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours. ADVANCES IN THERAPY. 2022; 39(6)DOI:10.1007/s12325-022-02080-x. PMID:35352310. IF:3.800(Q2/4D).
01/05/2022
Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC
Meler-Claramonte, C, Aviles-Jurado, FX, Vilaseca, I, Terra, X, Bragado, P, Fuster, G, Vintro, XL, Camacho, M. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC. Cancers. 2022; 14(9)DOI:10.3390/cancers14092259. PMID:35565388. IF:5.200(Q2/3D).
01/05/2022
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors
Rioja-Blanco E., Arroyo-Solera I., Álamo P., Casanova I., Gallardo A., Unzueta U., Serna N., Sánchez-García L., Quer M., Villaverde A., Vázquez E., Mangues R., Alba-Castellón L., León X.. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors. Acta Pharmaceutica Sinica B. 2022; 12(5)DOI:10.1016/j.apsb.2021.09.030. PMID:35646535. IF:14.500(Q1/1D).
01/04/2022
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
Rioja-Blanco, E, Gallardo, A, Arroyo-Solera, I, Alamo, P, Casanova, I, Unzueta, U, Serna, N, Sanchez-Garcia, L, Quer, M, Villaverde, A, Vazquez, E, Leon, X, Alba-Castellon, L, Mangues, R. A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model. Pharmaceutics. 2022; 14(4)DOI:10.3390/pharmaceutics14040887. PMID:35456719. IF:5.400(Q1/2D).